The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation

Current Opinion in Hematology

Volumn 20, Issue 4, 2013, Pages 314-319

  O'Leary, Heather ^a   Ou, Xuan ^a   Broxmeyer, Hal E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD26; Cord blood transplant; Dipeptidyl peptidase 4; Hematopoiesis

Indexed keywords

COLONY STIMULATING FACTOR; CYTOKINE; DIPEPTIDYL PEPTIDASE IV; PROTEIN; SITAGLIPTIN; TISSUE FACTOR PATHWAY INHIBITOR;

BLOOD CELL; CELL TRANSPLANTATION; CLINICAL TRIAL (TOPIC); CORD BLOOD STEM CELL TRANSPLANTATION; ENZYME ACTIVITY; HEMATOPOIESIS; HUMAN; INFLAMMATION; MEDICAL INFORMATION; MICROENVIRONMENT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

COLONY-STIMULATING FACTORS; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

EID: 84880197426     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32836125ac     Document Type: Review

References (37)

1. Shaheen M, Broxmeyer HE. Hematopoietic cytokines and growth factors. In: Broxmeyer HE, editor. Cord blood biology, transplantation, banking, and regulation. Bethesda, MD: AABB Press; 2011. pp. 35-74.
2. Shaheen M, Broxmeyer HE. Principles of cytokine signalling. In: Hoffman R, Benz Jr EJ, Silberstein LE, et al., editors. Hematology: basic principles and practice, 6th ed. Elsevier Churchill Livingstone: Philadelphia; 2012. Chapter pp. 136-146.
3. Campbell TB, Broxmeyer HE. CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation. Front Biosci 2008; 13:1795-1805.
4. Hopsu-Havu VK, Glenner GG. A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie 1966; 7:197-201.
5. Khurana S, Margamuljana L, Joseph C, et al. Glypican-3 mediated inhibition of CD26 by TFPI: a novel mechanism in hematopoietic stem cell homing and maintenance. Blood 2013. [Epub ahead of print] This is the first study to show a biological inhibitor of DPP4 that specifically has an impact on hematopoietic stem and progenitor cells.
6. Lambeir AM, Durinx C, Scharpe S, De Meester I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 2003; 40:209-294.
7. Solau-Gervais E, Zerimech F, Lemaire R, et al. Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2007; 36:373-377.
8. Lambeir AM, Diaz Pereira JF, Chacon P, et al. A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma. Biochim Biophys Acta 1997; 1340:215-226.
9. Bonig H, Priestley GV, Oehler V, Papayannopoulou T. Hematopoietic progenitor cells (HPC) from mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC. Exp Hematol 2007; 35:326-334.
10. Grim M, Carlson BM. Alkaline phosphatase and dipeptidylpeptidase IV staining of tissue components of skeletal muscle: a comparative study. J Histochem Cytochem 1990; 38:1907-1912.
11. Shigeta T, Aoyama M, Bando YK, et al. Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions. Circulation 2012; 126:1838-1851.
12. Moran GW, O'Neill C, Padfield P, McLaughlin JT. Dipeptidyl peptidase-4 expression is reduced in Crohn's disease. Regul Pept 2012; 177: 40-45.
13. Bengsch B, Seigel B, Flecken T, et al. Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26). J Immunol 2012; 188:5438-5447.
14. Miyazaki M, Kato M, Tanaka K, et al. Increased hepatic expression of dipeptidyl peptidase-4 in nonalcoholic fatty liver disease and its association with insulin resistance and glucose metabolism. Mol Med Rep 2012; 5:729-733.
15. Campbell TB, Hangoc G, Liu Y, et al. Inhibition of CD26 in human cord blood CD34Ã cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. Stem Cells Dev 2007; 16:347-354.
16. Christopherson KW 2nd, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 2003; 101:4680-4686.
17. Christopherson KW, Cooper S, Hangoc G, Broxmeyer HE. CD26 is essential for normal G-CSF induced progenitor cell mobilization as determined by CD26-/- mice. Exp Hematol 2003; 31:1126-1134.
18. Christopherson KW, Hangoc G, Broxmeyer HE. Cell surface peptidase CD26/DPP4 dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34Ã progenitor cells. J Immunol 2002; 169:7000-7008.
19. Christopherson KW 2nd, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004; 305:1000-1003.
20. Guo Y, Hangoc G, Bian H, et al. SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells 2005; 23:1324-1332.
21. Kidd S, Bueso-Ramos C, Jagan S, et al. In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice. Exp Hematol 2011; 39:580.e1-590.e1.
22. Christopherson KW 2nd, Frank RR, Jagan S, et al. CD26 protease inhibition improves functional response of unfractionated cord blood, bone marrow, and mobilized peripheral blood cells to CXCL12/SDF-1. Exp Hematol 2012; 40:945-952
23. Paganessi LA, Walker AL, Tan LL, et al. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis. Exp Hematol 2011; 39:384-390.
24. Yoo E, Paganessi LA, Alikhan WA, et al. Loss of CD26 protease activity in recipient mice during hematopoietic stem cell transplantation results in improved transplant efficiency. Transfusion 2012. [Epub ahead of print]
25. Parker MH, Loretz C, Tyler AE, et al. Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation. Skelet Muscle 2012; 2:4.
26. Jungraithmayr W, De Meester I, Matheeussen V, et al. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. Eur J Cardiothorac Surg 2012; 41:1166-1173.
27. Huber BC, Brunner S, Segeth A, et al. Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(Ã) stem cells into the ischaemic heart. Cardiovasc Res 2011; 90:529-537.
28. Broxmeyer HE, Hoggatt J, O'Leary HA, et al. Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis. Nat Med 2012; 18:1786-1796
29. Farag SS, Srivastava S, Messina-Graham S, et al. In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies. Stem Cells Dev 2013. [Epub ahead of print] This study is the first clinical trial evaluating the potential of DPP4 inhibition to increase the engraftment of patients receiving cord blood transplant.
30. Prabhash K, Khattry N, Bakshi A, et al. CD26 expression in donor stem cell harvest and its correlation with engraftment in human haematopoietic stem cell transplantation: potential predictor of early engraftment. Ann Oncol 2010; 21:582-588.
31. Cho SW, Pirih FQ, Koh AJ, et al. The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone. J Biol Chem 2013; 288:6814-6825.
32. Yoon KA, Cho HS, Shin HI, Cho JY. Differential regulation of CXCL5 by FGF2 in osteoblastic and endothelial niche cells supports hematopoietic stem cell migration. Stem Cells Dev 2012; 21:3391-3402.
33. Itkin T, Ludin A, Gradus B, et al. FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulation. Blood 2012; 120:1843-1855.
34. Krstic A, Kocic J, Ilic V, et al. Effects of IL-17 on erythroid progenitors growth: involvement of MAPKs and GATA transcription factors. J Biol Regul Homeost Agents 2012; 26:641-652.
35. Dyer KD, Percopo CM, Rosenberg HF. IL-33 promotes eosinophilia in vivo and antagonizes IL-5-dependent eosinophil hematopoiesis ex vivo. Immunol Lett 2013; 150:41-47.
36. Trottier MD, Naaz A, Li Y, Fraker PJ. Enhancement of hematopoiesis and lymphopoiesis in diet-induced obese mice. Proc Natl Acad Sci USA 2012; 109:7622-7629.
37. Cortez M, Carmo LS, Rogero MM, et al. A high-fat diet increases IL-1, IL-6, and TNF-alpha production by increasing NF-kappaB and attenuating PPAR-gamma expression in bone marrow mesenchymal stem cells. Inflammation 2013; 36:379-386.